Editorial Advisors
Russ Altman, Stanford University, United States of America
Charles Auffray, Centre National de la Recherche Scientifique, France
Alberto Bardelli, University of Torino and Candiolo Cancer Institute, Italy
Stephan Beck, University College London, United Kingdom
Mikael Benson, Linköping University Hospital, Sweden
Juergen Borlak, Hannover Medical School, Germany
Carl Borrebaeck, Lund University, Sweden
Atul Butte, UCSF School of Medicine, United States of America
Anne-Lise Børresen-Dale, University of Oslo, Norway
George Calin, MD Anderson Cancer Center, United States of America
Timothy Caulfield, University of Alberta, Canada
Richard Christopherson, University of Sydney, Australia
Angus Clarke, Cardiff University, United Kingdom
Ann Daly, Newcastle University, United Kingdom
Paul Edwards, Cambridge University, United Kingdom
Gary Gibbons, National Heart, Lung, and Blood Institute, United States of America
Takashi Gojobori, National Institute of Genetics, Japan
Julian Griffin, University of Cambridge, United Kingdom
Sean Grimmond, University of Melbourne, Australia
David Gurwitz, Tel-Aviv University, Israel
Martin Hibberd, London School of Hygiene and Tropical Medicine, United Kingdom
Robert Holt, British Columbia Cancer Agency, Canada
Leroy Hood, Institute for Systems Biology, United States of America
Matthew Hurles, Wellcome Trust Sanger Institute, United Kingdom
Curtis Huttenhower, Harvard T.H Chan School of Public Health, United States of America
Rima Kaddurah-Daouk, Duke University, United States of America
Jane Kaye, University of Oxford, United Kingdom
Muin Khoury, Centers for Disease Control and Prevention, United States of America
Bartha Maria Knoppers, McGill University, Canada
Isaac Kohane, Harvard Medical School, United States of America
Razelle Kurzrock, University of California San Diego School of Medicine and WIN Consortium for Personalized Cancer Therapy
Nuria Lopez-Bigas, University Pompeu Fabra, Spain
Jeantine Lunshof, VU University Amsterdam, Netherlands
James Lupski, Baylor College of Medicine, United States of America
Amy McGuire, Baylor College of Medicine, United States of America
Aleksandar Milosavljevic, Baylor College of Medicine, United States of America
Valerie Mizrahi, University of Cape Town, South Africa
Yves Moreau, University of Leuven, Belgium
Jeremy Nicholson, Imperial College London, United Kingdom
Stuart Orkin, Harvard Medical School, United States of America
Michael Owen, Cardiff University, United Kingdom
Munir Pirmohamed, University of Liverpool, United Kingdom
Heidi Rehm, Massachusetts General Hospital and Broad Institute of MIT and Harvard
Alexandre Reymond, University of Lausanne, Switzerland
H Hilger Ropers, Max-Planck Institute for Molecular Genetics, Germany
Charles Rotimi, National Institutes of Health, United States of America
Steven Rozen, Duke-NUS Graduate Medical School, Singapore
Stephen Scherer, The Hospital for Sick Children, Canada
Nicholas Schork, Craig Venter Research Institute, United States of America
Jay Shendure, University of Washington, United States of America
Richard Smith, Pacific Northwest National Laboratory, United States of America
Michael Snyder, Stanford University, United States of America
Nicole Soranzo, Wellcome Trust Sanger Institute, United Kingdom
Michael Speicher, Medical University of Graz, Austria
Barry Taylor, Memorial Sloan Kettering Cancer Center, United States of America
Toshikazu Ushijima, National Cancer Center Research Institute, Japan
Joris Veltman, University of Newcastle, United Kingdom
Marc Vidal, Dana-Farber Cancer Institute, United States of America
Peter Visscher, University of Queensland, Australia
Scott Weiss, Brigham and Women's Hospital, United States of America
Zemin Zhang, Peking University, China
